Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting

Simple item page
dc.contributor.authorKalshetty, A.
dc.contributor.authorRamaswamy, A.
dc.contributor.authorOstwal, V.
dc.contributor.authorBasu, Sandip
dc.date.accessioned2019-06-03T06:11:14Z
dc.date.available2019-06-03T06:11:14Z
dc.date.issued2018
dc.description.divisionRMCen
dc.format.extent5177 bytes
dc.format.mimetypetext/html
dc.identifier.sourceNuclear Medicine Communications, 2018. Vol. 39 (12): pp. 1143-1149en
dc.identifier.urihttp://hdl.handle.net/123456789/18622
dc.language.isoenen
dc.subjectfunctioning gastroenteropancreatic neuroendocrine tumorsen
dc.subject68Ga-DOTATATEen
dc.subject177Lu-DOTATATEen
dc.subjectneuroendocrine tumoren
dc.subjectpeptide receptor radionuclide therapyen
dc.titleResistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this settingen
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0997.htm
Size:
5.06 KB
Format:
Hypertext Markup Language
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

2018